«

»

Aug 28

A combined analysis of two trials comparing aspirin at 100 mg/day vs placebo in patients with recent deep vein thrombosis (DVT)

A combined analysis of two trials comparing aspirin at 100 mg/day vs placebo in patients with recent deep vein thrombosis (DVT) or pulmonary embolism (PE) has found that daily aspirin can reduce the adjusted recurrence risk by more than a third over three to four years after acute therapy for a first unprovoked venous thromboembolism (VTE). The analysis is published August 25 in Circulation.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>